Clotrimazole 1% (Empecid L Cream, BAYB5097)

Pre-clinicalCompleted
0 watching 0 views this week💤 Quiet
20
Hype Score

Development Stage

1
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Vaginal Candida

Conditions

Vaginal Candida

Trial Timeline

Jul 10, 2018 → Sep 3, 2021

About Clotrimazole 1% (Empecid L Cream, BAYB5097)

Clotrimazole 1% (Empecid L Cream, BAYB5097) is a pre-clinical stage product being developed by Bayer for Vaginal Candida. The current trial status is completed. This product is registered under clinical trial identifier NCT03599323. Target conditions include Vaginal Candida.

Hype Score Breakdown

Clinical
5
Activity
2
Company
7
Novelty
2
Community
1

Clinical Trials (1)

NCT IDPhaseStatus
NCT03599323Pre-clinicalCompleted